Related changes

Jump to navigation Jump to search

Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.

Recent changes options Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide registered users | Hide anonymous users | Hide my edits | Show bots | Hide minor edits
Show new changes starting from 03:47, 2 June 2024
   
Page name:
List of abbreviations:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes

1 June 2024

 m   04:01  Brentuximab vedotin (Adcetris) diffhist +134 Jwarner talk contribs →‎History of changes in PMDA indication
 m   03:43  Cytarabine (Ara-C) diffhist +156 Jwarner talk contribs →‎History of changes in PMDA indication

30 May 2024

     00:13  Peripheral T-cell lymphoma‎‎ 4 changes history +6,477 [Jwarner‎ (4×)]
     
00:13 (cur | prev) +2,002 Jwarner talk contribs →‎Pralatrexate monotherapy {{#subobject:c2c35b|Regimen=1}}
 m   
00:09 (cur | prev) +4,252 Jwarner talk contribs →‎DHAP {{#subobject:f4e87b|Regimen=1}}
 m   
00:08 (cur | prev) -1,840 Jwarner talk contribs →‎Bendamustine monotherapy {{#subobject:47c984|Regimen=1}}
 m   
00:05 (cur | prev) +2,063 Jwarner talk contribs →‎Gemcitabine monotherapy {{#subobject:7dbc1c|Regimen=1}}

28 May 2024

 m   23:12  Allogeneic HSCT diffhist +605 Jwarner talk contribs →‎References

14 May 2024

 m   00:31  Allogeneic HSCT diffhist +71 Jwarner talk contribs

10 May 2024

 m   20:25  Peripheral T-cell lymphoma diffhist +905 Jwarner talk contribs →‎CHOP {{#subobject:38ee4a|Regimen=1}}

9 May 2024

 m   02:38  Peripheral T-cell lymphoma‎‎ 2 changes history +5 [Warner-admin‎ (2×)]
 m   
02:38 (cur | prev) -16 Warner-admin talk contribs Text replacement - "https://www.nccn.org/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1483" to "https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1483"
 m   
02:13 (cur | prev) +21 Warner-admin talk contribs Text replacement - "https://www.nccn.org/professionals/physician_gls/pdf/t-cell.pdf" to "https://www.nccn.org/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1483"
 m   02:37  Anaplastic large cell lymphoma‎‎ 2 changes history +5 [Warner-admin‎ (2×)]
 m   
02:37 (cur | prev) -16 Warner-admin talk contribs Text replacement - "https://www.nccn.org/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1483" to "https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1483"
 m   
02:13 (cur | prev) +21 Warner-admin talk contribs Text replacement - "https://www.nccn.org/professionals/physician_gls/pdf/t-cell.pdf" to "https://www.nccn.org/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1483"